Abbisko Therapeutics, a Chinese oncology focused biopharmaceutical company, recently announced the completion of a US$70 million Series C financing, led by Temasek, joined by existing investors including Qiming Venture Partners, Jianxin Capital, GIC, Lilly Asia Ventures, CICC Capital, Loyal Valley Capital. This financing brings the total equity capital that the company has raised since its […] Temasek Leads $70M Series C Round In Chinese Biotech Firm Abbisko comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.